Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

TPEX:4111 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	419.2	443.91	336.19	381.05	456.25	252.27
Cash & Short-Term Investments	419.2	443.91	336.19	381.05	456.25	252.27
Cash Growth	30.46%	32.04%	-11.77%	-16.48%	80.86%	-24.88%
Accounts Receivable	377.84	352.14	326.5	309.71	282.64	281.4
Other Receivables	6.37	6.23	18.58	19.94	0.66	0.81
Receivables	384.21	358.37	345.07	329.65	283.3	282.2
Inventory	104.06	103.38	96.85	89.17	99.03	90.25
Prepaid Expenses	12.53	8.05	6.49	4.11	2.23	9.92
Other Current Assets	28.8	11.41	0.02	0.02	16.82	16.83
Total Current Assets	948.8	925.12	784.62	804	857.64	651.47
Property, Plant & Equipment	754.85	764.99	756.98	720.35	785.33	899.42
Long-Term Investments	1.8	1.81	1.81	1.84	3.48	3.97
Other Intangible Assets	1.2	1.41	1.63	1.46	1.04	0.9
Long-Term Deferred Tax Assets	2.9	6.61	11.23	35.54	54.2	6.1
Other Long-Term Assets	238.18	237.84	193.37	202.92	98.84	97.92
Total Assets	1,948	1,938	1,750	1,766	1,801	1,660

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	226.18	223.41	240.28	226.33	237.03	205.74
Short-Term Debt	10	10	10	120	120	130
Current Portion of Leases	5.16	7.47	9.53	2.12	6.11	6.72
Current Income Taxes Payable	50.66	39.1	1	1.2	18.7	14.01
Current Unearned Revenue	-	0.01	0.14	1.17	4.77	7.79
Other Current Liabilities	127.43	181.01	111.85	100.63	95.29	82.63
Total Current Liabilities	419.44	461	372.8	451.46	481.89	446.88
Long-Term Leases	5.32	6.43	7.09	0.78	2.28	7.28
Pension & Post-Retirement Benefits	5.27	-	8.89	11.24	9.08	18.61
Long-Term Deferred Tax Liabilities	77.59	78.67	79.94	76.52	77.85	76.52
Other Long-Term Liabilities	5.49	10.95	6.35	7.05	7.29	9.75
Total Liabilities	513.11	557.04	475.08	547.04	578.38	559.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	598.32	598.32	569.83	569.83	569.83	569.83
Additional Paid-In Capital	48.85	48.85	48.85	48.85	48.85	48.85
Retained Earnings	790.3	736.4	658.71	603.19	604.63	506.39
Comprehensive Income & Other	-2.84	-2.84	-2.84	-2.8	-1.16	-24.33
Shareholders' Equity	1,435	1,381	1,275	1,219	1,222	1,101
Total Liabilities & Equity	1,948	1,938	1,750	1,766	1,801	1,660

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	20.48	23.9	26.62	122.9	128.38	144
Net Cash (Debt)	398.72	420.01	309.57	258.15	327.87	108.27
Net Cash Growth	35.55%	35.68%	19.92%	-21.26%	202.84%	-66.51%
Net Cash Per Share	6.59	6.95	5.15	4.30	5.45	1.80
Filing Date Shares Outstanding	59.83	59.46	59.83	59.83	59.83	59.83
Total Common Shares Outstanding	59.83	59.46	59.83	59.83	59.83	59.83
Working Capital	529.37	464.12	411.82	352.54	375.74	204.59
Book Value Per Share	23.98	23.22	21.30	20.37	20.43	18.40
Tangible Book Value	1,433	1,379	1,273	1,218	1,221	1,100
Tangible Book Value Per Share	23.96	23.20	21.27	20.35	20.41	18.38
Land	371.9	-	371.9	371.9	478.28	478.28
Buildings	654.01	-	662.04	636.77	538.78	703.06
Machinery	596.4	-	585.74	549.8	529.11	569.08
Construction In Progress	75.34	-	36.28	30.51	82.48	2.96
Leasehold Improvements	3.95	-	2.44	2.29	3.41	3.41

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error